Search Results 801-810 of 17000 for monoclonal antibody

1. Immune globulin-stwk (intravenous route) - Mayo Clinic

   Description. Immune globulin-stwk injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

2. 1 Mayo Family Medicine Rochester Publications 2021 Journal publications with Family Medicine clinicians. Family Medicine authors

   A Mobile Unit Overcomes the Challenges to Monoclonal Antibody Infusion for COVID-. 19 in Skilled Care Facilities. J Am Geriatr Soc 2021;69(4):868-873. 66 ...

3. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma - Mayo Clinic

   About this study. This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called ...

4. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   ... monoclonal antibodies): 2 weeks. Immune-checkpoint inhibitors (e.g., anti-PD-1, anti-PD-L1, or anti-CTLA-4), monoclonal antibodies, antibody-drug conjugates ...

5. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

   Prior monoclonal antibody within 4 weeks prior to study Day 1 (2 weeks for RS participants) or who has not recovered (i.e. ≤ Grade 1 or at baseline) from ...

6. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   Participant has received immune therapy (monoclonal antibody therapy, checkpoint inhibitors) within 4 weeks of lymphodepletion. Participant had major ...

7. A Multicenter Assessment of ALD403 in Chronic Migraine - Mayo Clinic

   Receipt of any monoclonal antibody treatment within 6 months of screening (within or outside a clinical trial); Previously dosed with ALD403 or any ...

8. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - History of splenectomy within the 3 months prior to screening. - Received rituximab or other anti-CD20 monoclonal antibody <3 months prior to screening ...

9. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody within 4 weeks of Study Day 1 or who has not recovered from adverse events due to agents administered >4 weeks ...

10. Mayo Clinic expert explains why getting the COVID-19 vaccine is more important than ever

    "What they found in these studies is that you need a significantly higher titer, or concentration of antibodies, to neutralize omicron compared to delta or the ...